Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders

Alba Di Pardo(Istituto Neurologico Mediterraneo), Vittorio Maglione(Istituto Neurologico Mediterraneo)
Frontiers in Neuroscience
April 17, 2018
10.3389/fnins.2018.00249
Cited by 77

Related Papers

Impaired Ganglioside Metabolism in Huntington's Disease and Neuroprotective Role of GM1
|Journal of Neuroscience|2010|142
Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease
|Scientific Reports|2017|78
The longevity-associated variant of BPIFB4 improves a CXCR4-mediated striatum–microglia crosstalk preventing disease progression in a mouse model of Huntington’s disease
|Cell Death and Disease|2020|27